Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MDH1 pseudogene 1 (MDH1P1) is a human pseudogene related to the protein-coding gene *Malate dehydrogenase 1 (MDH1)*, which encodes a cytosolic enzyme important in the malate-aspartate shuttle and cellular metabolism. MDH1P1 does *not* encode a functional protein, and there is no evidence that it produces a biologically active product or serves as a direct therapeutic target. Pseudogenes such as MDH1P1 may be used as genomic landmarks but generally do not have functional relevance in cell signaling, disease, or therapy. Functional activity should not be confused with MDH1, which is a true enzyme involved in energy metabolism[1][5][3]. - If you intended to refer to the functional enzyme, see: **Malate dehydrogenase 1 (abbreviation: MDH1)**, which is a key enzyme in energy metabolism and *is* a viable research and therapeutic target[1][3][5]. - The canonical target **MDH1** is not the same as **MDH1P1**; the latter is a non-coding pseudogene. In summary: MDH1P1 is a pseudogene, not a protein-coding gene or druggable target, so it should *not* be considered a canonical or correct entry for most therapeutic, enzymatic, or receptor databases[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MDH1 pseudogene 1 (MDH1P1).